PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 126 filers reported holding PLIANT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,754 | -4.3% | 3,100 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $56,172 | -31.9% | 3,100 | 0.0% | 0.00% | -40.0% |
Q1 2023 | $82,460 | +37.6% | 3,100 | 0.0% | 0.01% | +25.0% |
Q4 2022 | $59,923 | -6.4% | 3,100 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $64,000 | +178.3% | 3,100 | 0.0% | 0.00% | +300.0% |
Q2 2022 | $23,000 | +9.5% | 3,100 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $21,000 | -48.8% | 3,100 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $41,000 | -22.6% | 3,100 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $53,000 | -39.1% | 3,100 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $87,000 | -15.5% | 3,100 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $103,000 | -15.6% | 3,100 | 0.0% | 0.00% | -40.0% |
Q4 2020 | $122,000 | +281.2% | 3,100 | +106.7% | 0.01% | +150.0% |
Q3 2020 | $32,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
Grace Capital | 48,058 | $808,000 | 0.50% |
Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |